381 related articles for article (PubMed ID: 35145236)
1. The use of new CRISPR tools in cardiovascular research and medicine.
Nishiga M; Liu C; Qi LS; Wu JC
Nat Rev Cardiol; 2022 Aug; 19(8):505-521. PubMed ID: 35145236
[TBL] [Abstract][Full Text] [Related]
2. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
3. The next generation of CRISPR-Cas technologies and applications.
Pickar-Oliver A; Gersbach CA
Nat Rev Mol Cell Biol; 2019 Aug; 20(8):490-507. PubMed ID: 31147612
[TBL] [Abstract][Full Text] [Related]
4. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
Briner AE; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
[TBL] [Abstract][Full Text] [Related]
5. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
6. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
8. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
Albadri S; Del Bene F; Revenu C
Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
[TBL] [Abstract][Full Text] [Related]
9. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
Kumar R; Tiwari K; Saudagar P
Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
11. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
Naeem M; Majeed S; Hoque MZ; Ahmad I
Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
[TBL] [Abstract][Full Text] [Related]
12. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
13. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review.
Bharathkumar N; Sunil A; Meera P; Aksah S; Kannan M; Saravanan KM; Anand T
Mol Biotechnol; 2022 Apr; 64(4):355-372. PubMed ID: 34741732
[TBL] [Abstract][Full Text] [Related]
15. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
[TBL] [Abstract][Full Text] [Related]
16. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
Briner AE; Henriksen ED; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
Batzir NA; Tovin A; Hendel A
Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
[TBL] [Abstract][Full Text] [Related]
18. Efficient CRISPR/Cas9-based genome editing in carrot cells.
Klimek-Chodacka M; Oleszkiewicz T; Lowder LG; Qi Y; Baranski R
Plant Cell Rep; 2018 Apr; 37(4):575-586. PubMed ID: 29332168
[TBL] [Abstract][Full Text] [Related]
19. qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites.
Dabrowska M; Czubak K; Juzwa W; Krzyzosiak WJ; Olejniczak M; Kozlowski P
Nucleic Acids Res; 2018 Sep; 46(17):e101. PubMed ID: 29878242
[TBL] [Abstract][Full Text] [Related]
20. Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing.
Tatiossian KJ; Clark RDE; Huang C; Thornton ME; Grubbs BH; Cannon PM
Mol Ther; 2021 Mar; 29(3):1057-1069. PubMed ID: 33160457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
